glucose, (beta-d)-isomer has been researched along with Candidiasis, Invasive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dreschers, S; Hornef, M; Morschhäuser, J; Orlikowsky, TW; Platen, C; Prehn, A; Saupp, P | 1 |
| Davis, LS; Flanigan, K; Liles, JE | 1 |
2 other study(ies) available for glucose, (beta-d)-isomer and Candidiasis, Invasive
| Article | Year |
|---|---|
Reduced PICD in Monocytes Mounts Altered Neonate Immune Response to Candida albicans.
Topics: Adult; Apoptosis; Candida albicans; Candidiasis, Invasive; Cells, Cultured; Cytokines; Diglycerides; Humans; Infant, Newborn; Lipopolysaccharides; Lipoproteins; Monocytes; Oligopeptides; Phagocytosis; Signal Transduction; Toll-Like Receptor 2; Zymosan | 2016 |
Association of IL-17 Inhibitor and SGLT2 Inhibitor with Candida Pyelonephritis.
Topics: Antibodies, Monoclonal, Humanized; Benzhydryl Compounds; Candida glabrata; Candidiasis, Invasive; Dermatologic Agents; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypoglycemic Agents; Insulin Detemir; Liraglutide; Middle Aged; Psoriasis; Pyelonephritis; Recurrence; Sepsis; Sodium-Glucose Transporter 2 Inhibitors; Urinary Tract Infections | 2021 |